High-performing, Accessible, and Affordable Imaging in Metastatic Prostate Cancer: Is Whole-body Magnetic Resonance Imaging the Answer?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-performing, Accessible, and Affordable Imaging in Metastatic Prostate Cancer: Is Whole-body Magnetic Resonance Imaging the Answer?

Published:2024-09 Issue:3 Volume:86 Page:275-277
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Adeleke Sola^ORCID

Publisher

Elsevier BV

Reference14 articles.

1. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the prostate cancer clinical trials working group 3;Scher;J Clin Oncol,2016

2. Rationale for modernising imaging in advanced prostate cancer;Padhani;Eur Urol Focus,2017

3. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer;Fanti;Eur J Nucl Med Mol Imaging,2021

4. Whole-body magnetic resonance imaging as a treatment response biomarker in castration-resistant prostate cancer with bone metastases: the iPROMET clinical trial;Garcia-Ruiz;Eur Urol,2024

5. Whole-body diffusion-weighted magnetic resonance imaging for assessment of the bone response rate in patients with metastatic hormone-sensitive prostate cancer receiving enzalutamide;Volta;Eur Urol,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3